Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
COX7B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
NUDT3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GUCY1A3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
C16orf92 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SLC12A2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LINC00304 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
PICALM - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SRP72 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RALBP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NDUFS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
USP14 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GPLD1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NUP43 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
UBA5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LRRC28 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KIF4A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SREK1IP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PTPN4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GRSF1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ATAD2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on